Editorial: Therapeutic potential of targeting BTLA

Journal of Leukocyte Biology

Volumn 86, Issue 1, 2009, Pages 5-8

  Crawford, Alison ^a   Wherry, E John ^a  

^a WISTAR INSTITUTE   (United States)

Author keywords

Adaptive immunity; Cell activation; Costimulation; Processes

Indexed keywords

ABATACEPT; BELATACEPT; BTLA ANTIBODY; CD79A ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4 ANTIBODY; HERPESVIRUS ENTRY MEDIATOR LIGAND; IMMUNOGLOBULIN ANTIBODY; IMMUNOGLOBULIN M; IMMUNOSUPPRESSIVE AGENT; IMP 321; IPILIMUMAB; MDX 1106 02; PD 1 ANTIBODY; RG 2077; RHIGM 12B7; UNCLASSIFIED DRUG; BTLA PROTEIN, MOUSE; IMMUNOGLOBULIN RECEPTOR; MONOCLONAL ANTIBODY;

AUTOIMMUNE DISEASE; B LYMPHOCYTE; DIABETES MELLITUS; DISEASE COURSE; DRUG MECHANISM; EDITORIAL; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SURVIVAL; T LYMPHOCYTE; ANIMAL; ANTIGEN PRESENTING CELL; IMMUNITY; IMMUNOLOGY; MOUSE; NOTE; PHYSIOLOGY;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGEN-PRESENTING CELLS; HUMANS; IMMUNITY; MICE; RECEPTORS, IMMUNOLOGIC; T-LYMPHOCYTES;

EID: 68849111961     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0209076     Document Type: Editorial

References (24)

1. Truong, W., Hancock, W. W., Plester, J. C., Merani, S., Rayner, D. C., Thangavelu, G., Murphy, K. M., Anderson, C. C., Shapiro, A. M. (2009) BTLA targeting modulates lymphocyte phenotype, function, and numbers and atttenuates disease in nonobese diabetic mice. J. Leukoc. Biol. 86, 41-51.
2. Gavrieli, M., Watanabe, N., Loftin, S. K., Murphy, T. L., Murphy, K. M. (2003) Characterization of phosphotyrosine binding motifs in the cytoplasmic domain of B and T lymphocyte attenuator required for association with protein tyrosine phosphatases SHP-1 and SHP-2. Biochem. Biophys. Res. Commun. 312, 1236-1243. (Pubitemid 37490949)
3. Krieg, C., Han, P., Stone, R., Goularte, O. D., Kaye, J. (2005) Functional analysis of B and T lymphocyte attenuator engagement on CD4+ and CD8+ T cells. J. Immunol. 175, 6420-6427. (Pubitemid 41598882)
4. Vendel, A. C., Calemine-Fenaux, J., Izrael-Tomasevic, A., Chauhan, V., Arnott, D., Eaton, D. L. (2009) B and T lymphocyte attenuator regulates B cell receptor signaling by targeting Syk and BLNK. J. Immunol. 182, 1509-1517.
5. Han, P., Goularte, O. D., Rufner, K., Wilkinson, B., Kaye, J. (2004) An inhibitory Ig superfamily protein expressed by lymphocytes and APCs is also an early marker of thymocyte positive selection. J. Immunol. 172, 5931-5939. (Pubitemid 38621192)
6. Hurchla, M. A., Sedy, J. R., Gavrieli, M., Drake, C. G., Murphy, T. L., Murphy, K. M. (2005) B and T lymphocyte attenuator exhibits structural and expression polymorphisms and is highly induced in anergic CD4+ T cells. J. Immunol. 174, 3377-3385.
7. Cai, G., Anumanthan, A., Brown, J. A., Greenfield, E. A., Zhu, B., Freeman, G. J. (2008) CD160 inhibits activation of human CD4+ T cells through interaction with herpesvirus entry mediator. Nat. Immunol. 9, 176-185.
8. Wu, T. H., Zhen, Y., Zeng, C., Yi, H. F., Zhao, Y. (2007) B and T lymphocyte attenuator interacts with CD3ζ and inhibits tyrosine phosphorylation of TCRζ complex during T-cell activation. Immunol. Cell Biol. 85, 590-595. (Pubitemid 350224202)
9. Chemnitz, J. M., Parry, R. V., Nichols, K. E., June, C. H., Riley, J. L. (2004) SHP-1 and SHP-2 associate with immunoreceptor tyrosine-based switch motif of programmed death 1 upon primary human T cell stimulation, but only receptor ligation prevents T cell activation. J. Immunol. 173, 945-954.
10. Teft, W. A., Kirchhof, M. G., Madrenas, J. (2006) A molecular perspective of CTLA-4 function. Annu. Rev. Immunol. 24, 65-97.
11. Deppong, C., Juehne, T. I., Hurchla, M., Friend, L. D., Shah, D. D., Rose, C. M., Bricker, T. L., Shornick, L. P., Crouch, E. C., Murphy, T. L., Holtzman, M. J., Murphy, K. M., Green, J. M. (2006) Cutting edge: B and T lymphocyte attenuator and programmed death receptor-1 inhibitory receptors are required for termination of acute allergic airway inflammation. J. Immunol. 176, 3909-3913. (Pubitemid 44264367)
12. Deppong, C., Degnan, J. M., Murphy, T. L., Murphy, K. M., Green, J. M. (2008) B and T lymphocyte attenuator regulates T cell survival in the lung. J. Immunol. 181, 2973-2979.
13. Iwai, Y., Terawaki, S., Ikegawa, M., Okazaki, T., Honjo, T. (2003) PD-1 inhibits antiviral immunity at the effector phase in the liver. J. Exp. Med. 198, 39-50. (Pubitemid 36870184)
14. Blazar, B. R., Taylor, P. A., Panoskaltsis-Mortari, A., Sharpe, A. H., Vallera, D. A. (1999) Opposing roles of CD28:B7 and CTLA-4:B7 pathways in regulating in vivo alloresponses in murine recipients of MHC disparate T cells. J. Immunol. 162, 6368-6377. (Pubitemid 29309356)
15. Blazar, B. R., Carreno, B. M., Panoskaltsis-Mortari, A., Carter, L., Iwai, Y., Yagita, H., Nishimura, H., Taylor, P. A. (2003) Blockade of programmed death-1 engagement accelerates graft-versus-host disease lethality by an IFN-γ-dependent mechanism. J. Immunol. 171, 1272-1277. (Pubitemid 36900057)
16. Hurchla, M. A., Sedy, J. R., Murphy, K. M. (2007) Unexpected role of B and T lymphocyte attenuator in sustaining cell survival during chronic allostimulation. J. Immunol. 178, 6073-6082.
17. Steinberg, M. W., Turovskaya, O., Shaikh, R. B., Kim, G., McCole, D. F., Pfeffer, K., Murphy, K. M., Ware, C. F., Kronenberg, M. (2008) A crucial role for HVEM and BTLA in preventing intestinal inflammation. J. Exp. Med. 205, 1463-1476. (Pubitemid 351831500)
18. Barber, D. L., Wherry, E. J., Masopust, D., Zhu, B., Allison, J. P., Sharpe, A. H., Freeman, G. J., Ahmed, R. (2006) Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439, 682-687. (Pubitemid 43237609)
19. Truong, W., Plester, J. C., Hancock, W. W., Merani, S., Murphy, T. L., Murphy, K. M., Kaye, J., Anderson, C. C., Shapiro, A. M. (2007) Combined coinhibitory and costimulatory modulation with anti-BTLA and CTLA4Ig facilitates tolerance in murine islet allografts. Am. J. Transplant. 7, 2663-2674. (Pubitemid 350045772)
20. Tao, R., Wang, L., Han, R., Wang, T., Ye, Q., Honjo, T., Murphy, T. L., Murphy, K. M., Hancock, W. W. (2005) Differential effects of B and T lymphocyte attenuator and programmed death-1 on acceptance of partially versus fully MHC-mismatched cardiac allografts. J. Immunol. 175, 5774-5782. (Pubitemid 41508061)
21. Lepenies, B., Pfeffer, K., Hurchla, M. A., Murphy, T. L., Murphy, K. M., Oetzel, J., Fleischer, B., Jacobs, T. (2007) Ligation of B and T lymphocyte attenuator prevents the genesis of experimental cerebral malaria. J. Immunol. 179, 4093-4100.
22. Truong, W., Plester, J. C., Hancock, W. W., Kaye, J., Merani, S., Murphy, K. M., Murphy, T. L., Anderson, C. C., Shapiro, A. M. (2007) Negative and positive co-signaling with anti-BTLA (PJ196) and CTLA4Ig prolongs islet allograft survival. Transplantation 84, 1368-1372. (Pubitemid 351339328)
23. Otsuki, N., Kamimura, Y., Hashiguchi, M., Azuma, M. (2006) Expression and function of the B and T lymphocyte attenuator (BTLA/CD272) on human T cells. Biochem. Biophys. Res. Commun. 344, 1121-1127.
24. Ansari, M. J., Salama, A. D., Chitnis, T., Smith, R. N., Yagita, H., Akiba, H., Yamazaki, T., Azuma, M., Iwai, H., Khoury, S. J., Auchincloss Jr., H., Sayegh, M. H. (2003) The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice. J. Exp. Med. 198, 63-69. (Pubitemid 36870186)